Nexiclon XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71511-503 -
Package NDC
71511-503-30 -
Application number
NDA022500 -
SPL ID
4f83c93a-721f-ca2f-e063-6394a90aa789 -
SPL set ID
dad35a6f-d57e-f302-e053-2995a90a9efb -
UNII
MN3L5RMN02 -
RxCUI
885880 -
RxCUI
1050338
What the source publishes
- Labeler
- Rosemont Pharmaceuticals LLC
- Active ingredients
- Clonidine
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Nexiclon XR",
"splId": "4f83c93a-721f-ca2f-e063-6394a90aa789",
"labels": [
{
"setId": "dad35a6f-d57e-f302-e053-2995a90a9efb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dad35a6f-d57e-f302-e053-2995a90a9efb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dad35a6f-d57e-f302-e053-2995a90a9efb"
}
],
"routes": [
"ORAL"
],
"labeler": "Rosemont Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71511-503-30)",
"package_ndc": "71511-503-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20220301"
}
],
"productId": "71511-503_4f83c93a-721f-ca2f-e063-6394a90aa789",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "71511-503",
"deaSchedule": null,
"genericName": "Clonidine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CLONIDINE",
"strength": ".17 mg/1"
}
],
"applicationNumber": "NDA022500",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220301",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000009918",
"N0000175554"
],
"unii": [
"MN3L5RMN02"
],
"rxcui": [
"885880",
"1050338"
],
"spl_set_id": [
"dad35a6f-d57e-f302-e053-2995a90a9efb"
],
"pharm_class_epc": [
"Central alpha-2 Adrenergic Agonist [EPC]"
],
"pharm_class_moa": [
"Adrenergic alpha2-Agonists [MoA]"
],
"manufacturer_name": [
"Rosemont Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71511-503_4f83c93a-721f-ca2f-e063-6394a90aa789"